Montone, Rocco Antonio
 Distribuzione geografica
Continente #
NA - Nord America 2.991
EU - Europa 2.963
AS - Asia 1.475
SA - Sud America 390
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 7.872
Nazione #
US - Stati Uniti d'America 2.945
DE - Germania 667
IT - Italia 615
SE - Svezia 614
SG - Singapore 555
CN - Cina 513
BR - Brasile 349
FR - Francia 262
IE - Irlanda 178
ID - Indonesia 113
FI - Finlandia 105
UA - Ucraina 105
RU - Federazione Russa 82
GB - Regno Unito 80
IN - India 71
PL - Polonia 61
AT - Austria 50
KR - Corea 43
HK - Hong Kong 34
TR - Turchia 34
CA - Canada 27
NL - Olanda 23
BE - Belgio 22
CZ - Repubblica Ceca 21
JP - Giappone 16
AR - Argentina 15
CH - Svizzera 15
IR - Iran 12
LT - Lituania 11
ES - Italia 10
BD - Bangladesh 9
TW - Taiwan 9
VN - Vietnam 9
EG - Egitto 8
MX - Messico 8
ZA - Sudafrica 8
IL - Israele 7
AU - Australia 6
CI - Costa d'Avorio 6
CL - Cile 6
EU - Europa 6
GR - Grecia 6
VE - Venezuela 6
PT - Portogallo 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BG - Bulgaria 4
CO - Colombia 4
EC - Ecuador 4
HU - Ungheria 4
IQ - Iraq 4
KE - Kenya 4
KZ - Kazakistan 4
LV - Lettonia 4
MA - Marocco 4
MY - Malesia 4
NO - Norvegia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CU - Cuba 3
RO - Romania 3
SA - Arabia Saudita 3
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
BO - Bolivia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
KH - Cambogia 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.872
Città #
Chandler 660
Singapore 384
Ashburn 256
Rome 185
Dublin 178
New York 149
Milan 133
Jakarta 110
San Mateo 98
The Dalles 82
Marseille 78
Los Angeles 72
Wilmington 68
Boston 67
Nanjing 66
Helsinki 63
Jacksonville 63
Beijing 58
Princeton 57
Frankfurt am Main 56
Moscow 55
Ann Arbor 52
Hefei 49
North Bergen 44
Seoul 41
Cattolica 40
Düsseldorf 40
Bremen 36
Vienna 36
Warsaw 33
Nuremberg 31
Munich 29
Nürnberg 29
Woodbridge 29
Hong Kong 26
São Paulo 26
Fairfield 25
Seattle 24
Redwood City 23
Brussels 22
Pune 22
Houston 21
Hyderabad 19
Chicago 18
Lauterbourg 18
Rio de Janeiro 18
Dearborn 17
Hangzhou 17
Lawrence 17
Leawood 16
Nanchang 16
Turku 16
Gmina Zabierzów 15
Andover 14
Belo Horizonte 14
Boardman 14
Shanghai 14
Izmir 13
Paris 13
Brno 12
Enterprise 12
Augusta 11
Lancaster 11
Tokyo 11
Guangzhou 10
London 10
San Francisco 10
Tianjin 10
Washington 10
Changsha 9
Kish 9
Ottawa 9
Redmond 9
Toronto 9
Venice 9
Council Bluffs 8
Falls Church 8
Kaohsiung City 8
Santa Clara 8
Bari 7
Brooklyn 7
Cambridge 7
Fremont 7
Jiaxing 7
Norwalk 7
Roubaix 7
Stockholm 7
Abidjan 6
Brasília 6
Busto Arsizio 6
Cairo 6
Campinas 6
Chennai 6
Detroit 6
Edinburgh 6
Faenza 6
Falkenstein 6
Istanbul 6
Lappeenranta 6
Mountain View 6
Totale 4.212
Nome #
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 194
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 183
Optical coherence tomography features of angiographic complex and smooth lesions in acute coronary syndromes 166
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 162
GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation 149
Eosinophili cationic protein: a new biomarker of coronary atherosclerosis 143
Air Pollution and Coronary Plaque Vulnerability and Instability: An Optical Coherence Tomography Study 133
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 130
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome 130
Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries 121
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 120
Identification of unique adaptive immune system signature in acute coronary syndromes 116
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 112
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 112
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study 104
Advances in mechanisms, imaging and management of the unstable plaque 104
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 103
Excimer laser for a highly stenotic saphenous vein graft: evidence of debulking by optical coherence tomography 97
Role of Allergic Inflammatory Cells in Coronary Artery Disease 97
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 95
Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications 95
Clinical predictors and prognostic role of high Killip class in patients with a first episode of anterior ST-segment elevation acute myocardial infarction 94
The evolving role of inflammatory biomarkers in risk assessment after stent implantation 92
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions 92
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries 88
Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of STEMI 85
Morphological-biohumoral correlations in acute coronary syndromes: Pathogenetic implications 84
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 83
Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty 82
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 82
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 81
Recurrent asymptomatic Takotsubo syndrome after 20 years: Are we looking at the tip of the iceberg only? 80
Coronary in-stent restenosis in patients treated with thoracic external beam radiation for cancer 77
Platelet hyaluronidase 2 enrichment in acute coronary syndromes: a conceivable role in monocyte-platelet aggregate formation 77
Brain-derived neurotrophic factor in patients with acute coronary syndrome 76
Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology 76
Omega-3 fatty acids supplementation and risk of atrial fibrillation: An updated meta-analysis of randomized controlled trials 76
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review 76
Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction 74
Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: A meta-analysis of randomized controlled trials 74
A Novel Monocyte Subset as a Unique Signature of Atherosclerotic Plaque Rupture 74
Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque Rupture 74
Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents 73
Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome 73
Human monocyte-derived macrophages: Pathogenetic role in plaque rupture associated to systemic inflammation 73
Left ventricular end-diastolic pressure predicts in-hospital outcomes in takotsubo syndrome 73
Angina after percutaneous coronary intervention: The need for precision medicine 72
Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty 71
Patients with acute myocardial infarction and non-obstructive coronary arteries: Safety and prognostic relevance of invasive coronary provocative tests 71
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 71
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 69
Coronary Microvascular Dysfunction Is Associated With a Worse Cardiac Phenotype in Patients With Fabry Disease 68
Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The “INOCA versus Obstructive CCS” Challenge 68
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions 67
Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis 67
Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge 66
"No-reflow": Update on diagnosis, pathophysiology and therapeutic strategies 64
Use of Levosimendan as bridge therapy to surgical correction of post-infarction ventricular septal defect: a case report 64
Colchicine in ischemic heart disease: the good, the bad and the ugly 64
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 63
Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus 63
Brain-derived neurotrophic factor in patients with acute coronary syndrome 62
Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: An updated meta-analysis 61
Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: A systematic review of the literature and meta-analysis 61
The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries 61
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial 60
Macrophage infiltrates in coronary plaque erosion and cardiovascular outcome in patients with acute coronary syndrome 59
Air pollution and plaque healing in acute coronary syndromes 58
Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives 57
Special Article - Emotional versus physical Takotsubo syndrome: Two faces of the same medal or two different syndromes? 57
Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond 57
Microvascular obstruction is an independent predictor of major adverse cardiovascular events in latecomers after ST-elevation myocardial infarction 54
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 53
Microvascular complications are associated with coronary collateralization in type 2 diabetes and chronic occlusion 51
Recurrence of angina after ST-segment elevation myocardial infarction: the role of coronary microvascular obstruction 51
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction 50
Management of non-culprit coronary plaques in patients with acute coronary syndrome 49
Platypnoea-Orthodeoxia Syndrome as an Uncommon Cause of Dyspnoea: a Literature Review 49
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 48
Safety and effectiveness of post percutaneous coronary intervention physiological assessment: Retrospective data from the post-revascularization optimization and physiological evaluation of intermediate lesions using fractional flow reserve registry 48
Air Pollution and Coronary Vasomotor Disorders in Patients With Myocardial Ischemia and Unobstructed Coronary Arteries 48
Myocardial infarction with non-obstructive coronary arteries: Dealing with pears and apples 47
Correction: Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries 45
Microbial signature of plaque and gut in acute coronary syndrome 44
Impact of acute and persistent stent malapposition after percutaneous coronary intervention on adverse cardiovascular outcomes 43
Cardiac Imaging in Childhood Cancer Survivors: A State-of-the-Art Review 42
Clinical Characteristics, Management, and Outcomes in Cardiogenic Shock: Insights From a High-Volume Italian Cardiac Intensive Care Unit 41
Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors 41
[Myocardial infarction with non-obstructive coronary artery disease: diagnostic work-up in the catheterization laboratory] 41
Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome? 39
Left atrial strain analysis improves left ventricular filling pressures non-invasive estimation in the acute phase of Takotsubo syndrome 39
Short-term air pollution exposure and mechanisms of plaque instability in acute coronary syndromes: An optical coherence tomography study 39
NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation 39
Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score 38
Access route for coronary chronic total occlusion: Femoral or radial approach? 38
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal 37
Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment 37
Atherosclerotic Coronary Plaque Features in Patients With Chronic Obstructive Pulmonary Disease and Acute Coronary Syndrome 35
Multivessel revascularization in non-ST segment elevation acute coronary syndromes: A systematic review and meta-analysis of 182,798 patients 35
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction 34
Totale 7.511
Categoria #
all - tutte 41.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 0 0 0 0 0 0 38
2020/2021380 11 25 7 28 33 41 54 25 40 26 72 18
2021/2022883 49 35 8 82 27 21 27 125 41 57 255 156
2022/20231.899 215 228 172 291 92 232 100 161 243 37 67 61
2023/20241.288 45 255 52 70 58 228 93 45 45 72 173 152
2024/20252.562 65 85 183 105 195 97 174 138 475 338 667 40
Totale 8.032